Chorionic villus sampling and amniocentesis for prenatal diagnosis

Lancet

Volumn 349, Issue 9053, 1997, Pages 711-714

  Stranc, Leonie C ^a   Evans, Jane A ^a   Hamerton, John L ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; FEMALE; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

EID: 0031030481     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)08169-X     Document Type: Review

References (30)

1. Bevis DC. The antenatal prediction of haemolytic disease of the newborn. Lancet 1952; i: 395-98.
2. Evans MI, Johnson MP, Holzgreve W. Early amniocentesis: what exactly does it mean? J Reprod M ed 1994; 39: 77-78.
3. Lippman A, Tomkins DT, Shine J, Hamerton JL, and the Canadian Collaborative CVS-amniocentesis Clinical Trial Group. Canadian multicentre randomised clinical trial of chorion villus sampling and amniocentesis: final report. Prenat Diag 1992; 12: 385-467.
4. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J M ed 1989; 320: 609-17.
5. Medical Research Council Working Party on the Evaluation of Chorion Villus Sampling. Medical Research Council European trial of chorion villus sampling. Lancet 1991; 337: 1491-99.
6. Firth HV, Boyd PA, Chamberlain P, MacKenzie IZ. Lindebaum RH, Huson SM. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet 1991; 337: 762-63.
7. Burton BK, Schulz CJ, Burd LI. Limb anomalies associated with chorionic villus sampling. Obstet Gynecol 1992; 79: 726-30.
8. Cutillo DM, Hammond EA, Reeser SL, et al. Chorionic villus sampling utilization following reports of a possible association with fetal limb defects. Prenat Diagn 1994; 14: 327-32.
9. Evans JA, Hamerton JL. Limb defects and chorionic villus sampling. Lancet 1996; 347: 484.
10. Desnick RJ, Schuette JL, Golbus MS, et al. First-trim ester biochemical and molecular diagnoses using chorionic villi: high accuracy in the US collaborative study. Prenat Diagn 1992; 12: 357-72.
11. Gray RG, Green A, Cole T, et al. A misdiagnosis of X-linked adrenoleukodystrophy in cultured chorionic villus cells by the measurement of very long chain fatty acids. Prenat Diagn 1995; 15: 486-90.
12. Castellvi-Bel S, Montserrat M, Soler A, et al. Prenatal diagnosis of fragile X syndrome: (CGN)n expansion and methylation of chorionic villus samples. Prenat Diagn 1995; 15: 801-07.
13. Tabor A, Madsen M, Obel EB, Philip J, Bang J, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; i: 1287-92.
14. Smidt-Jensen S, Permin M, Philip J, et al. Randomised comparison of amniocentesis and transabdominal and transcervical villus sampling. Lancet 1992; 340: 1237-44.
15. Smidt-Jensen S, Philip J. Comparison of transabdominal and transcervical CVS and amniocentesis: sampling success and risk. Prenat Diagn 1991; 11: 529-37.
16. Canadian College of Medical Genetics and the Society of Obstetricians and Gynaecologists of Canada. Canadian Guidelines for prenatal diagnosis of genetic disorders: an update. J Soc Obstet Gynaecol Can 1993; 15 (suppl): 16-39.
17. Burke BM, Kolker A. Clients undergoing chorionic villus sampling versus amniocentesis: contrasting attitudes toward pregnancy. Health Care Women Int 1993; 14: 193-200.
18. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality, United States, 1972 through 1987. Am J Obstet Gynecol 1994; 171: 193-200.
19. Kyle PM, Evans JA, MacDonald KM, Harman CR, Menticoglou SM, Manning FA. Life without amniocentesis: elevated maternal serum alpha-fetoprotein (MSAFP) in the Manitoba programme 1986-1991. Ultrasound Obstet Gynecol 1994; 4: 199-204.
20. Heckerling PS, Verp MS, Hadro TA. Preferences of pregnant women for amniocentesis or chorionic villus sampling for prenatal testing: comparison of patients' choices and those of a decision-analytic model. J Clin Epidemiol 1994; 47: 1215-28.
21. Evans MI, Pryde PG, Evans WJ, Johnson MP. The choices women make about prenatal diagnosis. Fetal Diagn Ther 1993; 8 (suppl 1): 70-80.
22. Hamerton JL, Evans JA, Stranc LC. Prenatal diagnosis in Canada - 1990: a review of genetic centres. In: Research studies of the Royal Commission on New Reproductive Technologies: vol 13. Ottawa: Supply and Services Canada, 1993: 1-184.
23. Nicolaides K, de Lourdes Brizot M, Patel F, Snijders R. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation. Lancet 1994; 344: 435-39.
24. Johnson JM, Wilson RD, Winsor EJ, Singer J, Dansereau J, Kalousek DK. The early amniocentesis study: a randomised clinical trial of early amniocentesis versus midtrimester amniocentesis. Fetal Diagn Ther 1996; 11: 85-93.
25. Eiben B, Goebel R, Hansen S, Hammans W. Early amniocentesis - a cytogenetic evaluation of over 1500 cases. Prenat Diagn 1994; 14: 497-501.
26. NICHHD National Registry for Amniocentesis Study Group. Midtrimester amniocentesis for Prenatal Diagnosis. Safety and accuracy. JAMA 1976; 236: 1471-76.
27. Crandall BF, Chua C. Detecting neural tube defects by amniocentesis between 11 and 15 weeks' gestation. Prenat Diagn 1995; 15: 339-43.
28. Ledbetter DH, Zachary JM, Simpson JL, et al. Cytogenetic results from the US collaborative study on CVS. Prenat Diagn 1992; 12: 317-45.
29. Hsu LY, Perils TE. United States survey on chromosome mosaicism and pseudomosaicism in prenatal diagnosis. Prenat Diagn 1984; 4: 97-130.
30. Bernaschek G, Yildiz A, Kolankaya A, Stuempflen I, Deutinger J. Complications of cordocentesis in high-risk pregnancies: effects on fetal loss or preterm delivery. Prenat Diagn 1995; 15: 995-1000.